新的MRI特征改善肝细胞腺瘤的亚型分类
该回顾性研究分析116例肝细胞腺瘤的病理与影像数据,评估MRI对亚型分类的特征与限度。HNF1α突变型腺瘤以脂肪成分和乏血供模式鉴别,敏感度88%、特异度97%;炎症型腺瘤以窦状扩张相关模式(含新发现的「新月征」)鉴别,敏感度88%、特异度100%。β-catenin突变型及未分类腺瘤无特异性MRI模式;直径小于5.2 cm和4.2 cm时分别未观察到恶变和出血。
要点
- HNF1α突变型腺瘤MRI特征为脂肪成分(均匀或不均匀)和乏血供模式,敏感度88%、特异度97%。
- 炎症型腺瘤窦状扩张表现为整体窦状扩张、环礁征及新发现的「新月征」,敏感度88%、特异度100%。
- 病灶坏死/出血改变超过50%、无脂肪变的HNF1α突变型、无窦状扩张的炎症型及β-catenin突变型腺瘤MRI无法分类。
核心结论
- 基于迄今最大样本系列,研究识别了多个未描述的MRI特征,提出新的高敏感度和高特异度MRI标准,可使88%的两大主要肝细胞腺瘤亚型得到识别。
研究设计与样本
- 回顾性分析116例肝细胞腺瘤的病理和影像数据,评估MRI特征与病理亚型及并发症风险的关系。
关键影像表现/征象
- HNF1α突变型腺瘤表现为脂肪成分(均匀或不均匀)和乏血供模式。
- 炎症型腺瘤显示窦状扩张特征,包括整体窦状扩张、环礁征及新发现的「新月征」——部分周边环状,T2WI和/或动脉期高信号,延迟期持续强化。
- 部分腺瘤MRI无法分类:坏死/出血改变覆盖超过50%的病灶、无脂肪变的HNF1α突变型、无窦状扩张的炎症型、β-catenin突变型及未分类腺瘤。
诊断标准与关键数值
- HNF1α突变型腺瘤:脂肪成分(均匀或不均匀)加乏血供模式,敏感度88%、特异度97%(38/43例,88%被鉴别)。
- 炎症型腺瘤:窦状扩张特征(整体窦状扩张、环礁征、新月征),敏感度88%、特异度100%(51/58例,88%显示特征)。
- β-catenin突变型腺瘤:未识别出特异性MRI模式。
临床应用与阅片要点
- 阅片时可依据脂肪成分和乏血供模式提示HNF1α突变型腺瘤。
- 窦状扩张相关模式(含新月征)有助于识别炎症型腺瘤。
- 坏死/出血覆盖超过50%的病灶及无相应特征的腺瘤可能无法通过MRI分类。
- 直径小于5.2 cm时未观察到恶变,直径小于4.2 cm时未观察到出血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: MRI is crucial for the classification of hepatocellular adenomas (HCA) into subtypes. Our objective was to review and increase MRI criteria for subtype classification and define the limits.
METHODS: Pathological and radiological data of 116 HCAs were retrospectively analyzed to investigate MRI features of HCA pathological subtypes. Risk for complication was also evaluated with regard to subtype and tumor size.
RESULTS: 38/43 (88%) HNF1α-mutated HCAs (H-HCAs) were discriminated by (i) fatty component (homogeneous or heterogeneous) and (ii) hypovascular pattern, with a sensitivity of 88% and a specificity of 97%. 51/58 (88%) inflammatory HCAs (IHCAs) displayed features of sinusoidal dilatation (SD) including three different patterns (global SD, atoll sign, and a new "crescent sign" corresponding to a partial peripheral rim, hyperintense on T2W and/or arterial phase with persistent delayed enhancement). Sensitivity was 88% and specificity 100%. However, some HCA remained unclassifiable by MRI: HCA remodeled by necrotic/hemorrhagic changes covering > 50% of the lesion, H-HCAs without steatosis, IHCAs without SD, β-catenin-mutated and unclassified HCAs. Regarding malignant transformation (5/116) and bleeding (24/116), none was observed when the HCA diameter was smaller than 5.2 cm and 4.2 cm, respectively.
CONCLUSION: Based on the largest series evaluated until now, we identified several non-described MRI features and propose new highly sensitive and specific MRI criteria. With the addition of these new features, 88% of the two main HCA subtypes could be identified.
KEY POINTS: • HNF1α-mutated hepatocellular adenomas (H-HCA) are characterized by the presence of fat and hypovascular pattern in MRI. • Inflammatory hepatocellular adenomas (I-HCA) are characterized by different patterns translating sinusoidal dilatation including the newly described crescent sign. • No MRI specific pattern was identified for β-catenin-mutated HCA (b-HCA).
引用
- Bise S, Frulio N, Hocquelet A, et al. New MRI features improve subtype classification of hepatocellular adenoma. Eur Radiol. 2018. PMID: 30523457. doi:10.1007/s00330-018-5784-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。